Financials·Life & Health Insurance·$5.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.98 | N/A | -56.30% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.98 | N/A | -56.30% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns over current financial performance and highlighted the importance of adapting strategies to improve results.
Management acknowledged challenges in achieving profitability.
They emphasized the need for strategic adjustments moving forward.
Oscar Health's disappointing EPS indicates ongoing struggles with profitability, contributing to a 7.36% drop in stock price. Investors may be concerned about the company's ability to navigate its financial challenges without clear guidance or a path to improvement. The lack of revenue data further complicates the outlook.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AIR PRODS & CHEMS IN
May 10, 2021